Among the 10 patients who did not achieve CR, 2 patients achieved PR with ongoing response, 1 patient died of severe CRS and 1 because of disease progression The other six continued to receive the second course of CAR-T therapy targeting CD20 or CD22, and three of them achieved CR. The gene discussed is CD22; the disease is congenital rubella syndrome.